• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房利钠因子对血压及肾素-血管紧张素-醛固酮系统的影响。

Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.

作者信息

Atlas S A, Volpe M, Sosa R E, Laragh J H, Camargo M J, Maack T

出版信息

Fed Proc. 1986 Jun;45(7):2115-21.

PMID:2940120
Abstract

Atrial natriuretic factor (ANF) antagonizes vasoconstriction induced by numerous smooth muscle agonists and also lowers blood pressure in intact animals. ANF has particularly marked relaxant effects on angiotensin II-contracted vessels in vitro. Sensitivity to the blood pressure-lowering effect of ANF in vivo appears to be enhanced in renin-dependent models of renovascular hypertension compared with other experimental hypertensive models. The depressor action of low, possibly physiological doses of ANF in two-kidney, one-clip Goldblatt rats is due to a decrease in total peripheral resistance. On the other hand, high doses of ANF can lower cardiac output, particularly in volume-expanded models such as deoxycorticosterone-salt hypertension. ANF markedly inhibits renin secretion in intact animals, probably via increased glomerular filtration rate and load of sodium chloride to the macula densa. This effect is masked when renal perfusion is impaired (e.g., via unilateral renal artery constriction), in which case ANF may stimulate renin secretion slightly. ANF also reduces plasma aldosterone in vivo and inhibits basal and agonist-induced aldosterone release from isolated adrenal cortical cells. This effect appears to be especially marked for angiotensin-induced aldosterone production in vivo and in vitro. These findings indicate that ANF has potentially important interactions with the renin-angiotensin-aldosterone system and suggest a role for ANF in the homeostatic control of blood pressure as well as of extracellular fluid volume.

摘要

心房利钠因子(ANF)可拮抗多种平滑肌激动剂诱导的血管收缩,并降低完整动物的血压。在体外,ANF对血管紧张素II收缩的血管具有特别显著的舒张作用。与其他实验性高血压模型相比,在肾血管性高血压的肾素依赖性模型中,体内对ANF降压作用的敏感性似乎增强。低剂量(可能是生理剂量)的ANF对两肾一夹型Goldblatt大鼠的降压作用是由于总外周阻力降低。另一方面,高剂量的ANF可降低心输出量,特别是在容量扩张模型中,如脱氧皮质酮-盐性高血压。ANF在完整动物中显著抑制肾素分泌,可能是通过增加肾小球滤过率和致密斑处氯化钠的负荷。当肾灌注受损时(如通过单侧肾动脉狭窄),这种作用会被掩盖,在这种情况下,ANF可能会轻微刺激肾素分泌。ANF还可降低体内血浆醛固酮水平,并抑制离体肾上腺皮质细胞基础及激动剂诱导的醛固酮释放。这种作用在体内和体外对血管紧张素诱导的醛固酮生成似乎尤为显著。这些发现表明,ANF与肾素-血管紧张素-醛固酮系统存在潜在的重要相互作用,并提示ANF在血压以及细胞外液容量的稳态控制中发挥作用。

相似文献

1
Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.心房利钠因子对血压及肾素-血管紧张素-醛固酮系统的影响。
Fed Proc. 1986 Jun;45(7):2115-21.
2
Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.合成心房利钠因子在肾素依赖性肾血管性高血压中的降压及降醛固酮作用
J Hypertens Suppl. 1984 Dec;2(3):S313-5.
3
Effects of atrial natriuretic factor on the kidney and the renin-angiotensin-aldosterone system.心房利钠因子对肾脏及肾素-血管紧张素-醛固酮系统的作用。
Endocrinol Metab Clin North Am. 1987 Mar;16(1):107-43.
4
Atrial natriuretic factor (auriculin): structure and biological effects.心房利钠因子(心钠素):结构与生物学效应。
J Clin Hypertens. 1985 Jun;1(2):187-98.
5
Effect of atrial natriuretic factor on renin and aldosterone.心房利钠因子对肾素和醛固酮的影响。
J Cardiovasc Pharmacol. 1989;13 Suppl 6:S31-5.
6
The endocrine control of blood volume, blood pressure and sodium balance: atrial hormone and renin system interactions.血容量、血压和钠平衡的内分泌调控:心房激素与肾素系统的相互作用
J Hypertens Suppl. 1986 Jun;4(2):S143-56.
7
Renal hemodynamic and natriuretic effects of atrial natriuretic factor.
Fed Proc. 1986 Jun;45(7):2128-32.
8
Effect of atrial natriuretic factor on blood pressure, renin, and aldosterone in Goldblatt hypertension.心房利钠因子对戈德布拉特高血压模型中血压、肾素和醛固酮的影响。
Hypertension. 1985 May-Jun;7(3 Pt 2):I43-8. doi: 10.1161/01.hyp.7.3_pt_2.i43.
9
Effect of atrial natriuretic factor on renin secretion, plasma renin and aldosterone in dogs with acute unilateral renal artery constriction.心房利钠因子对急性单侧肾动脉狭窄犬肾素分泌、血浆肾素及醛固酮的影响。
J Hypertens Suppl. 1985 Dec;3(3):S299-302.
10
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.心房利钠激素、肾素-醛固酮轴与血压-电解质稳态。
N Engl J Med. 1985 Nov 21;313(21):1330-40. doi: 10.1056/NEJM198511213132106.

引用本文的文献

1
Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure.钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂对心力衰竭生物标志物的影响
Cells. 2025 Jun 18;14(12):919. doi: 10.3390/cells14120919.
2
Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review.心力衰竭早期检测中的新型生物标志物:一篇叙述性综述。
Cureus. 2024 Feb 2;16(2):e53445. doi: 10.7759/cureus.53445. eCollection 2024 Feb.
3
Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions.利钠肽作为生物标志物:在心血管和呼吸功能障碍中的叙述性综述及考虑因素。
Yale J Biol Med. 2023 Mar 31;96(1):137-149. doi: 10.59249/NCST6937. eCollection 2023 Mar.
4
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era.SARS-CoV-2 时代利钠肽的当代观点
Front Physiol. 2021 Jul 16;12:643721. doi: 10.3389/fphys.2021.643721. eCollection 2021.
5
Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension.血浆心钠素及电解质水平与原发性高血压的关系
Exp Ther Med. 2013 May;5(5):1439-1443. doi: 10.3892/etm.2013.991. Epub 2013 Mar 6.
6
Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat.心房利钠因子可增加大鼠脾脏微血管压力及液体外渗。
J Physiol. 2001 May 15;533(Pt 1):273-80. doi: 10.1111/j.1469-7793.2001.0273b.x.
7
Hyperreninemic hypoaldosteronism after chronic stress in the rat.大鼠慢性应激后高肾素性低醛固酮血症
J Clin Invest. 1995 Sep;96(3):1512-9. doi: 10.1172/JCI118189.
8
Atrial natriuretic factor: a hormone secreted by the heart.心房利钠因子:一种由心脏分泌的激素。
Pharm Weekbl Sci. 1987 Dec 11;9(6):305-14. doi: 10.1007/BF01956510.
9
Dissociation of blood volume and flow in regulation of salt and water balance in burn patients.烧伤患者盐水平衡调节中血容量与血流的解离
Ann Surg. 1991 Sep;214(3):213-8; discussion 218-20. doi: 10.1097/00000658-199109000-00004.